アパルタミドによる薬物誘発過敏症候群の症例
Yuki Tanaka1, Yui Fujimura1, Koya Morishita1
1Okazaki City Hospital Okazaki Aichi Japan.
IJU case reports
|September 5, 2025
まとめ
前立腺がんに使用されるアパルタミドは,薬剤誘発過敏症候群 (DIHS) を稀に引き起こします. ステロイドとIVIGの迅速な認識と治療は,この重度の副作用を効果的に管理することができます.
科学分野:
- 腫瘍学
- 薬理学について
- 毒理学について
背景:
- アパルタミドは,前立腺がんの治療において重要なアンドロゲン受容体の抗体です.
- 薬剤誘発過敏症候群 (DIHS) は珍しいが深刻な薬剤の副作用です.
- DIHSの早期発見と治療は 患者のアウトカムにとって不可欠です
研究 の 目的:
- 前立腺がん患者のアパルウタミド治療に関連した薬物誘発過敏症候群 (DIHS) の報告
- アパルウタミド誘発性DIHSの臨床表現,診断基準,および成功管理を強調する.
- アパルウタミドを投与する患者におけるDIHSの注意深い監視の重要性を強調する.
主な方法:
- アパルウタミドとGnRHアンタゴニストで治療された転移性前立腺がんの75歳の男性に関するケース研究.
- 発疹,肝機能障害 (CTCAE分類),発熱を含む有害事象の臨床モニタリング
- 確立された基準に基づいてDIHSの診断評価
- 診断時にプレドニソロンと静脈内免疫グロブリン (IVIG) による治療
主要な成果:
- アパルウタミド投与開始から3週間後,患者は2度目の発疹,3度目の肝機能障害,熱を発症した.
- 症状はグレード3の発疹とグレード4の肝機能障害に進行し,5つのDIHS診断基準を満たした.
- アパルウタミドを中止し,プレドニソロンとIVIGを投与すると,疲労,発疹,肝機能が急速に改善しました.
- 患者はアビラテロンとGnRHアンタゴニストによる治療を許容し,有害事象は再発しなかった.
結論:
- アパルタミドは薬剤誘発過敏症候群 (DIHS) を誘発し,患者の注意深いモニタリングが必要である.
- アパルタミド誘発性DIHSの管理には,コルチコステロイドとIVIGの迅速な認識と介入が有効である.
- アパルウタミド治療を受ける患者には,重度の副作用のリスクを軽減するために,定期的な検査と臨床的警戒が不可欠です.
関連する概念動画
Desensitization and Tachyphylaxis
2.1K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
2.1K
Allergic Drug Reactions
971
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
971
Hypersensitivities
1.0K
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
1.0K
Pharmacovigilance
981
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
981
Antihypertensive Drugs: Potassium-Sparing Diuretics
746
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
746
Nephrotic Syndrome I : Introduction
25
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
25


